ALPS earnings: real EPS beat/miss history, P/E -0.03. Updated 2026-07-23.
Alps Group (ALPS) Research Hub
Alps Group (ALPS) trades on NASDAQ, MY in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 0.4 USD (+3.90%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.03, market cap 0.08B. This hub links to the full technical, earnings and options research available for ALPS.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, MY |
| Last close | 0.4 USD (+3.90%) |
| 52-week range | 0.2685 USD – 0.77 USD |
| Trend regime | Range |
| 14-day RSI | 48 (Neutral) |
| Trailing P/E | -0.03 |
| Market cap | 0.08B |
| Dividend yield | 0.00% |
Available research for ALPS
Covered Call on ALPS: how it works, illustrative setup around the real 0.4 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ALPS: how it works, illustrative setup around the real 0.4 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ALPS: how it works, illustrative setup around the real 0.4 USD price, max profit/loss, breakeven and when to use it. Educational.
ALPS technical analysis: range, last 0.4 USD, RSI 48, 52w range 0.2685 USD–0.77 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is ALPS in?
Alps Group (ALPS) is classified under Healthcare (Biotechnology), listed on NASDAQ, MY.
Is ALPS in an uptrend or downtrend?
As of 2026-09-11, ALPS is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ALPS's trailing P/E ratio?
ALPS's trailing P/E is -0.03, with a market cap of 0.08B. See the earnings research page for full valuation detail.